VivoSeq
Other

Pediatric Patients

0

Pipeline Programs↗

26

Active Trials↗

41

Companies Involved↗

Pediatric Patients is an early-stage landscape with 0 programs across 41 companies. The most active players are Pfizer, Sanofi, Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

39/100

Pipeline Velocity

27/100

Mech. Concentration

N/A

Completion Rate

78/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalNovartis logo

Novartis

0 programs

PreclinicalC

Cumberland Pharmaceuticals

0 programs

PreclinicalOtsuka logo

Otsuka

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

186

clinical trials

Completed107 · 58%
Terminated26 · 14%
Unknown status19 · 10%
Recruiting16 · 9%
Withdrawn5 · 3%
Active, not recruiting4 · 2%
Other9 · 5%

Clinical Trials

Trial Activity

186 trials

A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
Recruiting·Otsuka logoOtsuka·Phase 3·NCT07087327·180 enrolled
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Recruiting·WWake Forest University Health Sciences·Phase 2·NCT04948619·64 enrolled
To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH
Recruiting·SShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.·Phase 2·NCT05997602·56 enrolled
A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients
Recruiting·JJiangsu HengRui Medicine Co., Ltd.·Phase 4·NCT06344091·232 enrolled
A Crossover Clinical Study to Evaluate the Effect of Chitosan Mouthwash on Recurrence of Black Stains in Pediatric Patients
Recruiting·—·N/A·NCT06714695·17 enrolled
Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Recruiting·SStanford University·Phase 1·NCT05188170·16 enrolled
Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients with Ventriculitis
Recruiting·—·Phase 4·NCT06151392·140 enrolled
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
Recruiting·UUniversity of Colorado, Denver·Phase 4·NCT06860711·80 enrolled
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Recruiting·Novartis logoNovartis·Phase 3·NCT06994845·31 enrolled
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
Recruiting·MMilestone Pharmaceuticals Inc.·Phase 2·NCT05763953·60 enrolled
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Recruiting·FFresenius·N/A·NCT06274788·40 enrolled
Coconut Oil to Prevent Mouth Sores in Pediatric Patients Receiving High Dose Chemotherapy
Recruiting·WWake Forest University Health Sciences·Phase 2·NCT05441813·60 enrolled
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Recruiting·GGE Healthcare·Phase 1/2·NCT04604782·54 enrolled
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
Recruiting·Sanofi logoSanofi·N/A·NCT06192576·10 enrolled
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
Recruiting·—·N/A·NCT06326983·58 enrolled
Page 1 of 13

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)